At both pre- and post-immunization the levels of CD4+ for the 20mg/kg APS treated group was higher than for all other groups; while CD4+ levels for the 5mg/kg APS treatment group increased post-immunization. The gene discussed is CD4; the disease is autoimmune polyendocrinopathy.